Mid-term results of mitral valve palsty in patients with mitral sclerotic lesion

Masanori Hirota, Tadashi Isomura, Chieko Katsumata, Fusahiko Ito, Masazumi Watanabe

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Mitral valve repair is preferred over prosthetic replacement. We surgically repaired mitral valve with degenerated sclerotic lesion and demonstrated mid-term results. Methods: Mitral valve plasty (MVP) was performed with several procedures including ring annuloplasty, leaflet slicing and decalcification. Results: There were 19 males and 19 females with a mean age of 67 ± 12 y.o (n = 38). All patients were successfully treated MVP except one case with unrepairable injuries of the thin leaflet. In patients underwent MVP (n = 37), MVP included ring annuloplasty with a rigid full ring of 32 ± 2 mm (n = 37), leaflet slicing (n = 37), decalcification (n = 15) and artificial chordae (n = 14). Mitral valve area was statistically enlarged by MVP (1.65 ± 0.57 vs 2.51 ± 0.58 cm2, p < 0.001). Left atrial diameter was statistically reduced after the operation (55 ± 10 vs 46 ± 9 mm, p < 0.001). Severity of MR and right ventricular systolic pressure (RVSP) were statistically decreased after the operation (MR; 1.8 ± 1.0 vs 0.7 ± 0.9, p < 0.001, RVSP; 38 ± 15 vs 30 ± 9 mm Hg, p < 0.001). There were 4 cases with residual MR (Grade II, n = 3; Grade III, n = 1). The 30-days mortality was 0 %. There was one late death due to non-cardiogenic cause (the 3-year survival rate of 97 %) and no redo case due to deterioration of the mitral valve during follow-up period of 21 ± 13 months. Conclusions: Successful mid-term survival and freedom from reoperation might expect to the durability of MVP in patients with mitral sclerotic lesion.

Original languageEnglish
Article number81
JournalJournal of Cardiothoracic Surgery
Volume11
Issue number1
DOIs
Publication statusPublished - May 10 2016
Externally publishedYes

Fingerprint

Mitral Valve
Ventricular Pressure
Blood Pressure
Reoperation
Survival Rate
Survival
Mortality
Wounds and Injuries

Keywords

  • Mitral stenosis
  • Mitral valve plasty
  • Rheumatic valvular disease

ASJC Scopus subject areas

  • Surgery
  • Cardiology and Cardiovascular Medicine

Cite this

Mid-term results of mitral valve palsty in patients with mitral sclerotic lesion. / Hirota, Masanori; Isomura, Tadashi; Katsumata, Chieko; Ito, Fusahiko; Watanabe, Masazumi.

In: Journal of Cardiothoracic Surgery, Vol. 11, No. 1, 81, 10.05.2016.

Research output: Contribution to journalArticle

Hirota, Masanori ; Isomura, Tadashi ; Katsumata, Chieko ; Ito, Fusahiko ; Watanabe, Masazumi. / Mid-term results of mitral valve palsty in patients with mitral sclerotic lesion. In: Journal of Cardiothoracic Surgery. 2016 ; Vol. 11, No. 1.
@article{5e6e61f606c94ad999e669cead2285d6,
title = "Mid-term results of mitral valve palsty in patients with mitral sclerotic lesion",
abstract = "Background: Mitral valve repair is preferred over prosthetic replacement. We surgically repaired mitral valve with degenerated sclerotic lesion and demonstrated mid-term results. Methods: Mitral valve plasty (MVP) was performed with several procedures including ring annuloplasty, leaflet slicing and decalcification. Results: There were 19 males and 19 females with a mean age of 67 ± 12 y.o (n = 38). All patients were successfully treated MVP except one case with unrepairable injuries of the thin leaflet. In patients underwent MVP (n = 37), MVP included ring annuloplasty with a rigid full ring of 32 ± 2 mm (n = 37), leaflet slicing (n = 37), decalcification (n = 15) and artificial chordae (n = 14). Mitral valve area was statistically enlarged by MVP (1.65 ± 0.57 vs 2.51 ± 0.58 cm2, p < 0.001). Left atrial diameter was statistically reduced after the operation (55 ± 10 vs 46 ± 9 mm, p < 0.001). Severity of MR and right ventricular systolic pressure (RVSP) were statistically decreased after the operation (MR; 1.8 ± 1.0 vs 0.7 ± 0.9, p < 0.001, RVSP; 38 ± 15 vs 30 ± 9 mm Hg, p < 0.001). There were 4 cases with residual MR (Grade II, n = 3; Grade III, n = 1). The 30-days mortality was 0 {\%}. There was one late death due to non-cardiogenic cause (the 3-year survival rate of 97 {\%}) and no redo case due to deterioration of the mitral valve during follow-up period of 21 ± 13 months. Conclusions: Successful mid-term survival and freedom from reoperation might expect to the durability of MVP in patients with mitral sclerotic lesion.",
keywords = "Mitral stenosis, Mitral valve plasty, Rheumatic valvular disease",
author = "Masanori Hirota and Tadashi Isomura and Chieko Katsumata and Fusahiko Ito and Masazumi Watanabe",
year = "2016",
month = "5",
day = "10",
doi = "10.1186/s13019-016-0473-4",
language = "English",
volume = "11",
journal = "Journal of Cardiothoracic Surgery",
issn = "1749-8090",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Mid-term results of mitral valve palsty in patients with mitral sclerotic lesion

AU - Hirota, Masanori

AU - Isomura, Tadashi

AU - Katsumata, Chieko

AU - Ito, Fusahiko

AU - Watanabe, Masazumi

PY - 2016/5/10

Y1 - 2016/5/10

N2 - Background: Mitral valve repair is preferred over prosthetic replacement. We surgically repaired mitral valve with degenerated sclerotic lesion and demonstrated mid-term results. Methods: Mitral valve plasty (MVP) was performed with several procedures including ring annuloplasty, leaflet slicing and decalcification. Results: There were 19 males and 19 females with a mean age of 67 ± 12 y.o (n = 38). All patients were successfully treated MVP except one case with unrepairable injuries of the thin leaflet. In patients underwent MVP (n = 37), MVP included ring annuloplasty with a rigid full ring of 32 ± 2 mm (n = 37), leaflet slicing (n = 37), decalcification (n = 15) and artificial chordae (n = 14). Mitral valve area was statistically enlarged by MVP (1.65 ± 0.57 vs 2.51 ± 0.58 cm2, p < 0.001). Left atrial diameter was statistically reduced after the operation (55 ± 10 vs 46 ± 9 mm, p < 0.001). Severity of MR and right ventricular systolic pressure (RVSP) were statistically decreased after the operation (MR; 1.8 ± 1.0 vs 0.7 ± 0.9, p < 0.001, RVSP; 38 ± 15 vs 30 ± 9 mm Hg, p < 0.001). There were 4 cases with residual MR (Grade II, n = 3; Grade III, n = 1). The 30-days mortality was 0 %. There was one late death due to non-cardiogenic cause (the 3-year survival rate of 97 %) and no redo case due to deterioration of the mitral valve during follow-up period of 21 ± 13 months. Conclusions: Successful mid-term survival and freedom from reoperation might expect to the durability of MVP in patients with mitral sclerotic lesion.

AB - Background: Mitral valve repair is preferred over prosthetic replacement. We surgically repaired mitral valve with degenerated sclerotic lesion and demonstrated mid-term results. Methods: Mitral valve plasty (MVP) was performed with several procedures including ring annuloplasty, leaflet slicing and decalcification. Results: There were 19 males and 19 females with a mean age of 67 ± 12 y.o (n = 38). All patients were successfully treated MVP except one case with unrepairable injuries of the thin leaflet. In patients underwent MVP (n = 37), MVP included ring annuloplasty with a rigid full ring of 32 ± 2 mm (n = 37), leaflet slicing (n = 37), decalcification (n = 15) and artificial chordae (n = 14). Mitral valve area was statistically enlarged by MVP (1.65 ± 0.57 vs 2.51 ± 0.58 cm2, p < 0.001). Left atrial diameter was statistically reduced after the operation (55 ± 10 vs 46 ± 9 mm, p < 0.001). Severity of MR and right ventricular systolic pressure (RVSP) were statistically decreased after the operation (MR; 1.8 ± 1.0 vs 0.7 ± 0.9, p < 0.001, RVSP; 38 ± 15 vs 30 ± 9 mm Hg, p < 0.001). There were 4 cases with residual MR (Grade II, n = 3; Grade III, n = 1). The 30-days mortality was 0 %. There was one late death due to non-cardiogenic cause (the 3-year survival rate of 97 %) and no redo case due to deterioration of the mitral valve during follow-up period of 21 ± 13 months. Conclusions: Successful mid-term survival and freedom from reoperation might expect to the durability of MVP in patients with mitral sclerotic lesion.

KW - Mitral stenosis

KW - Mitral valve plasty

KW - Rheumatic valvular disease

UR - http://www.scopus.com/inward/record.url?scp=84968880342&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84968880342&partnerID=8YFLogxK

U2 - 10.1186/s13019-016-0473-4

DO - 10.1186/s13019-016-0473-4

M3 - Article

C2 - 27160266

AN - SCOPUS:84968880342

VL - 11

JO - Journal of Cardiothoracic Surgery

JF - Journal of Cardiothoracic Surgery

SN - 1749-8090

IS - 1

M1 - 81

ER -